wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35832370-6F4D254D-2DEE-4DEF-BE2E-1D46C326CB1F
Q35832370-6F4D254D-2DEE-4DEF-BE2E-1D46C326CB1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35832370-6F4D254D-2DEE-4DEF-BE2E-1D46C326CB1F
The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers.
P2860
Q35832370-6F4D254D-2DEE-4DEF-BE2E-1D46C326CB1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35832370-6F4D254D-2DEE-4DEF-BE2E-1D46C326CB1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e939643bc79ea7a98561f0fc4cd3a2bc699c706
P2860
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study